Vimarsana
Biggest News Aggregation in the World

Page 8 - Director Peter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Peter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Peter Today - Breaking & Trending Today

ResMed Inc. (RMD) To Go Ex-Dividend on May 8th - Vimarsana News

ResMed Inc. (RMD) To Go Ex-Dividend on May 8th

ResMed Inc. (NYSE:RMD – Get Free Report) announced a quarterly dividend on Thursday, April 25th, Zacks reports. Shareholders of record on Thursday, May 9th will be given a dividend of 0.48 per share by the medical equipment provider on Thursday, June 13th. This represents a $1.92 dividend on an annualized basis and a yield of […]

ResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer - Vimarsana News

ResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer

ResMed (NYSE:RMD – Get Free Report) had its target price dropped by equities researchers at Oppenheimer from $205.00 to $200.00 in a research report issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Oppenheimer’s price target suggests a potential downside of 7.91% from the company’s current […]

Source: wkrb13.com
ResMed (NYSE:RMD) PT Raised to $238.00 - Vimarsana News

ResMed (NYSE:RMD) PT Raised to $238.00

ResMed (NYSE:RMD – Get Free Report) had its target price upped by equities research analysts at KeyCorp from $227.00 to $238.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. KeyCorp’s price target would suggest a potential upside of 29.75% from the […]

Source: wkrb13.com
ResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer - Vimarsana News

ResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer

ResMed (NYSE:RMD – Get Free Report) had its target price dropped by equities researchers at Oppenheimer from $205.00 to $200.00 in a research report issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the medical equipment provider’s stock. Oppenheimer’s price target suggests a potential downside of 7.91% from the company’s current […]

ResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer - Vimarsana News

ResMed (NYSE:RMD) Given New $200.00 Price Target at Oppenheimer

ResMed (NYSE:RMD – Get Free Report) had its price objective decreased by equities researchers at Oppenheimer from $205.00 to $200.00 in a research note issued to investors on Friday, Benzinga reports. The brokerage currently has an “outperform” rating on the medical equipment provider’s stock. Oppenheimer’s target price would indicate a potential downside of 7.91% from […]